BACKGROUND: Environmental risk factors together with genetic vulnerability create a complex background to develop depression. METHODS: We investigated the associations between COMT Val(158)Met and depression in a Swedish population-based sample of 405 depressed individuals (major depression diagnosis, dysthymia or mixed anxiety depression defined according to DSM-IV) and 2,151 healthy controls. We also analyzed interaction between this genetic variation and some environmental risk factors for depression and the link between this polymorphism and the low motivational level and negative mood state found in depressed individuals. RESULTS: Depressed individuals displayed a higher frequency of the Met/Met and Met/Val genotypes compared to controls (OR=1.49, CI(95%)=1.11-2.00, P=0.009). The association was found among men only (OR=2.26, CI(95%)=1.26-4.05, p=0.008). Regression analysis including some potential risk factors for depression, did further indicate that Met/Met and Met/Val were associated with depression in men (P=0.005). There was also an interaction between genotype and family childhood problems (RERI=0.876, CI(95%)=0.090-1.662 and AP=0.426, CI(95%)=0.030-0.821). Further, depressed men homozygous for the Val-allele, had a higher motivational level than depressed men with a Met-variant (P=0.02). LIMITATIONS: The sample size of depressed individuals per group when stratifying cases according to gender and genotypes is considered a limitation. CONCLUSIONS: The Met-variants of COMT Val(158)Met are risk variants for depression and low motivational level in depressed Swedish men, but not women. Individuals with this risk variant in combination with a problematic childhood, have an even higher risk to develop depression.
BACKGROUND: Environmental risk factors together with genetic vulnerability create a complex background to develop depression. METHODS: We investigated the associations between COMTVal(158)Met and depression in a Swedish population-based sample of 405 depressed individuals (major depression diagnosis, dysthymia or mixed anxiety depression defined according to DSM-IV) and 2,151 healthy controls. We also analyzed interaction between this genetic variation and some environmental risk factors for depression and the link between this polymorphism and the low motivational level and negative mood state found in depressed individuals. RESULTS:Depressed individuals displayed a higher frequency of the Met/Met and Met/Val genotypes compared to controls (OR=1.49, CI(95%)=1.11-2.00, P=0.009). The association was found among men only (OR=2.26, CI(95%)=1.26-4.05, p=0.008). Regression analysis including some potential risk factors for depression, did further indicate that Met/Met and Met/Val were associated with depression in men (P=0.005). There was also an interaction between genotype and family childhood problems (RERI=0.876, CI(95%)=0.090-1.662 and AP=0.426, CI(95%)=0.030-0.821). Further, depressedmen homozygous for the Val-allele, had a higher motivational level than depressedmen with a Met-variant (P=0.02). LIMITATIONS: The sample size of depressed individuals per group when stratifying cases according to gender and genotypes is considered a limitation. CONCLUSIONS: The Met-variants of COMTVal(158)Met are risk variants for depression and low motivational level in depressed Swedish men, but not women. Individuals with this risk variant in combination with a problematic childhood, have an even higher risk to develop depression.
Authors: Lee X Blonder; John T Slevin; Richard J Kryscio; Catherine A Martin; Anders H Andersen; Charles D Smith; Frederick A Schmitt Journal: Psychiatry Res Date: 2013-07-06 Impact factor: 3.222
Authors: Joaquim Radua; Wissam El-Hage; Gemma C Monté; Benedicte Gohier; Maria Tropeano; Mary L Phillips; Simon A Surguladze Journal: Soc Cogn Affect Neurosci Date: 2013-06-06 Impact factor: 3.436
Authors: Marco Bortolato; Consuelo Walss-Bass; Peter M Thompson; Jackob Moskovitz Journal: World J Biol Psychiatry Date: 2016-07-26 Impact factor: 4.132
Authors: Haroon I Sheikh; Katie R Kryski; Heather J Smith; Lea R Dougherty; Daniel N Klein; Sara J Bufferd; Shiva M Singh; Elizabeth P Hayden Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2013-03-08 Impact factor: 3.568
Authors: Nicholas S Roetker; C David Page; James A Yonker; Vicky Chang; Carol L Roan; Pamela Herd; Taissa S Hauser; Robert M Hauser; Craig S Atwood Journal: Am J Public Health Date: 2013-08-08 Impact factor: 9.308